Article Versions Notes

Smith K, Zubair RU, Smith RV, Augustine S, Schlecht NF, Ow TJ, Prystowsky MB, Belbin TJ. ZNF671 Silencing Affects Signaling Pathways in Head and Neck Cancer via Activation of Oncogenic Non-Coding RNAs. Biomedicines. 2024; 12(11):2482. https://doi.org/10.3390/biomedicines12112482

Smith, Kendra, Rufa’i Umar Zubair, Richard V. Smith, Stelby Augustine, Nicholas F. Schlecht, Thomas J. Ow, Michael B. Prystowsky, and Thomas J. Belbin. 2024. "ZNF671 Silencing Affects Signaling Pathways in Head and Neck Cancer via Activation of Oncogenic Non-Coding RNAs" Biomedicines 12, no. 11: 2482. https://doi.org/10.3390/biomedicines12112482

Smith, K., Zubair, R. U., Smith, R. V., Augustine, S., Schlecht, N. F., Ow, T. J., Prystowsky, M. B., & Belbin, T. J. (2024). ZNF671 Silencing Affects Signaling Pathways in Head and Neck Cancer via Activation of Oncogenic Non-Coding RNAs. Biomedicines, 12(11), 2482. https://doi.org/10.3390/biomedicines12112482